Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:08:59.927Z.
Calculation as of: 2026-10-06T16:08:59.927Z.
Quote observation: 2026-10-06T16:05:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7a3ccde1bd0df5c55ebc0148063105fff0bf751cb52a3071af3e3331f6001fbe
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$503.89M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$486.87M
Free Cash Flow Yield
8.44%
TTM Avg
13.01%
3Y Avg
15.56%
5Y Avg
14.39%
Market Cap
$509.64M
Free Cash Flow Yield
0.09%
TTM Avg
0.12%
3Y Avg
0.12%
5Y Avg
0.12%
Market Cap
$479.39M
Free Cash Flow Yield
N/A
TTM Avg
18.77%
3Y Avg
18.69%
5Y Avg
14.04%
Market Cap
$474.21M
Free Cash Flow Yield
N/A
TTM Avg
3.93%
3Y Avg
3.93%
5Y Avg
3.93%
Market Cap
$472.82M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$472.58M
Free Cash Flow Yield
N/A
TTM Avg
1.11%
3Y Avg
1.42%
5Y Avg
1.42%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oculis Holding AG (OCS) | $496.23M | N/A | N/A | N/A | N/A |
| Evolus, Inc. (EOLS)vs › | $490.62M | N/A | N/A | N/A | N/A |
| Allogene Therapeutics, Inc. (ALLO)vs › | $503.89M | N/A | N/A | N/A | N/A |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.87M | 8.44% | 13.01% | 15.56% | 14.39% |
| 908 Devices Inc. (MASS)vs › | $509.64M | 0.09% | 0.12% | 0.12% | 0.12% |
| Arvinas, Inc. (ARVN)vs › | $479.39M | N/A | 18.77% | 18.69% | 14.04% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $474.21M | N/A | 3.93% | 3.93% | 3.93% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.82M | N/A | N/A | N/A | N/A |
| Cerus Corporation (CERS)vs › | $472.58M | N/A | 1.11% | 1.42% | 1.42% |
| Kamada Ltd. (KMDA)vs › | $472.52M | 5.60% | 4.46% | 4.74% | 4.69% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
